Speakers - Beverly Hills
Principal, ARRAHealth Consulting, Inc., Contributing Editor, Health IT Leaders & News
Editor-in-Chief
Healthcare Informatics
Chief Technology Officer, California Telehealth Network
Richard brings over 25 years of management experience and has been a strategic and thought leader in IT and Information Security for both the private and public sectors. His Project Management, Security Operations, and Policy and Compliance experience has helped shape his broad perspective on creating and implementing Information Security Programs in organizations.
Richard is actively involved in the Information Security community, serving on the Boards of the Los Angeles Chapters of both ISSA and OWASP. He is also a member of the ISSA CISO Executive Program, where he collaborates with other Information Security Officers from around the country.
Richard recently was awarded Senior Member standing in ISSA by the Fellow Selection Committee. He also served on the ISSA International Conference - Attendee Development Committee and the CISO Forum - Planning Committee.
Richard currently serves on the OWASP Global Conference Committee, and co-chaired the highly successful OWASP Global AppSec USA 2010 Conference. He is a member of the IANS Pacific Security Forum Steering Committee and the CISO Executive Summit Governing Body in Southern California.
Mark Hagland, Editor-in-Chief, Healthcare Informatics
Glenn has over 30 years of experience in the hospital field. He served for 19+ years as Executive Vice President at Georgia Hospital Association in Marietta, Georgia where he provided leadership in the following areas:
- Financial Services (Medicare, Medicaid, commercial payers, etc.)
- mHealth/Digital Health and Emerging Technologies
- Georgia Hospital Health Systems, Inc. (For-profit entrepreneurial subsidiary)
- Public Relations and Communications
- Data Services
- GHA’s Information Technology infrastructure
Dr. Weingarten has held positions on myriad national committees dedicated to improving patient outcomes, including those of the Institute for Medical Quality, the American Heart Association’s "Get With The Guidelines" program, and the quality improvement committee of the board of directors of St. Joseph's Health System. He is currently a Board of Director for the Scottsdale Institute. At Cedars-Sinai, he has been awarded both the President’s Award and the Golden Apple Teaching Award, and was Alumnus of the Year for 2009.
Dr. Weingarten was the co-founder, president and chief executive officer of Zynx Health, which is the leader for order sets and care plans for electronic health records. Scott sold Zynx Health to the Cerner Corporation and later to the Hearst Corporation. Zynx Health is one of the Hearst Corporation’s larger companies. He is a co-inventor of three software patents granted by the United States Patent and Trademark Office.
After graduating from UCLA’s medical school, Dr. Weingarten completed his internship, residency and fellowship in internal medicine at Cedars-Sinai. He later participated in a National Center for Health Services Research Fellowship at the RAND/UCLA Center for Health Policy Study. During the fellowship, he also earned a master’s of Public Health degree at the UCLA Fielding School of Public Health. Dr. Weingarten has also worked as a primary care physician at Kaiser Permanente and was awarded partnership status at Southern California Permanente Medical Group.
Mr. You has also been directly involved in policy-making efforts with a focus on biosecurity. He served as a Working Group member for the National Security Council Interagency Policy Committee on Countering Biological Threats and is a current Ex Officio member of the NIH National Science Advisory Board for Biosecurity. He also serves on two National Academies committees, the Institute of Medicine’s Forum on Microbial Threats and the Committee on Science, Technology, and Law’s Forum on Synthetic Biology.
Prior to joining the FBI, Mr. You worked for six years in graduate research focusing on retrovirology and human gene therapy at the University of Southern California, Keck School of Medicine. He subsequently worked for three years at the biotechnology firm AMGEN Inc. in cancer research.